Arena Pharmaceuticals [NASDAQ:ARNA] to issue more stock |
Biotechnology Companies | |||
Written by Hugh McManus | |||
Warning: mktime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /hermes/bosnacweb08/bosnacweb08az/b29/ipw.wellbeyo/public_html/libraries/joomla/utilities/date.php on line 119 Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /hermes/bosnacweb08/bosnacweb08az/b29/ipw.wellbeyo/public_html/libraries/joomla/utilities/date.php on line 247 Warning: date(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /hermes/bosnacweb08/bosnacweb08az/b29/ipw.wellbeyo/public_html/libraries/joomla/utilities/date.php on line 251 Warning: strftime(): It is not safe to rely on the system's timezone settings. You are *required* to use the date.timezone setting or the date_default_timezone_set() function. In case you used any of those methods and you are still getting this warning, you most likely misspelled the timezone identifier. We selected the timezone 'UTC' for now, but please set date.timezone to select your timezone. in /hermes/bosnacweb08/bosnacweb08az/b29/ipw.wellbeyo/public_html/libraries/joomla/utilities/date.php on line 252 Wednesday, 05 May 2010 10:53 |
|||
A form S-3 Registration Statement appeared on the Arena Pharmaceuticals website; the company may now issue an additional $150 million in new securities. An S-3 appeared on the Arena Pharmaceuticals website allowing the company to issue up to an additional $150 million in mixed securities. The document starts off: "We may, from time to time, offer to sell up to $150,000,000 of any combination of the securities described in this prospectus, either individually or in units, at prices and on terms described in one or more supplements to this prospectus." invest.arenapharm.com/secfiling.cfm?filingID=1193125-10-104544 The company may issue additional shares of common stock, preferred stock, debt securities or warrants. The preferred shares would undoubtedly be convertible. With a market cap today of $323 million, if this dilution were applied immediately, the share price could drop as low as $2.19. The bigger question is what does this move mean for lorcaserin—the drug on which the future of this company depends? It seems to me that having this option could mean one of two things: (a) The company is having difficulty finding a marketing partner for lorcaserin, so it needs the extra cash to ensure the successful launch of the drug; As of its last reported numbers, the company has close to $120 million in cash and cash equivalents on hand. Jack Lief, the CEO of Arena, is holding a webcast tomorrow, so many of these questions could be answered then. The link to this webcast is provided next.
|